Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ESC 2026 28 - 31 August 2026

Cardiovascular outcomes by baseline blood pressure control status in persons with type 2 diabetes at high cardiovascular risk treated with oral semaglutide

Authors :

N. Poulter¹; S. L Mulvagh²; S. E Inzucchi³; R Pop-Busui⁴; J. F. E Mann⁵; N Marx⁶; J. E Deanfield⁷; S Rasmussen⁸; S Prabhu⁹; A Mircea-Catarig⁸; D. K McGuire¹⁰

Affiliations

View Details Hide Details

Keywords

Cardiovascular Disease

Congress oral presentation